BTX ECM399 Electroporation System

Overview

The BTX ECM399 Electroporation System is a dual-mode, benchtop electroporator engineered for high-precision molecular delivery across diverse biological systems. It delivers programmable square-wave and exponential decay pulses—two fundamental waveforms essential for optimizing transfection efficiency and cell viability across distinct cell types and experimental objectives. Unlike single-waveform instruments, the ECM399 enables researchers to select the optimal pulse profile: square-wave pulses provide tightly controlled duration and amplitude (ideal for mammalian cells, primary cultures, and sensitive adherent lines), while exponential decay pulses offer rapid, high-voltage delivery suited for bacterial and yeast transformation. Its modular architecture supports seamless integration with standardized electroporation cuvettes (e.g., 0.1 cm, 0.2 cm, and 0.4 cm gap widths) and specialized electrodes—including coaxial electrodes (Model 747) for low-volume or in vivo applications. Designed and manufactured in the United States, the ECM399 complies with IEC 61010-1 safety standards for laboratory electrical equipment and meets electromagnetic compatibility (EMC) requirements per FCC Part 15 and CE directives.

Key Features

• Dual waveform capability: Independently selectable square-wave and exponential decay pulse modes
• Precise parameter control: Adjustable voltage (10–3000 V), pulse length (1 µs–99 ms), number of pulses (1–99), and interval between pulses (0.1–10 s)
• Real-time monitoring: Built-in impedance sensing and arc detection to prevent sample damage and ensure reproducible field strength delivery
• Programmable protocols: Up to 24 user-defined methods stored in non-volatile memory; recallable via front-panel interface or external software
• Robust thermal management: Active cooling system maintains consistent electrode temperature during repeated runs, critical for maintaining membrane integrity in heat-sensitive cells
• Compliance-ready design: Supports audit trails and electronic signatures when used with validated BTX Control Software (optional), aligning with GLP/GMP documentation practices

Sample Compatibility & Compliance

The ECM399 demonstrates broad compatibility across prokaryotic and eukaryotic systems without requiring species-specific hardware modifications. It is routinely validated for use with Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Hansenula polymorpha, human T lymphocytes, COS-7 fibroblasts, murine dendritic cells, primary neurons, and intact plant protoplasts. For bacterial transformation, typical efficiencies reach 1 × 10¹⁰ CFU/µg plasmid DNA in chemically competent E. coli strains under optimized square-wave conditions (e.g., 1.8 kV, 1 ms, 1 pulse). In yeast, protocols using intact cells (no enzymatic wall digestion) yield >3 × 10⁵ transformants/µg DNA. The system conforms to ISO/IEC 17025 calibration traceability guidelines when operated with NIST-traceable voltage verification tools. All accessories—including BTX-certified electroporation cuvettes and coaxial electrodes—undergo bioburden testing and are supplied sterile or RNase/DNase-free upon request.

Software & Data Management

The ECM399 operates standalone via its intuitive membrane keypad interface but integrates natively with BTX Control Software (v4.2+), a Windows-based application supporting method synchronization, real-time waveform visualization, and export of timestamped parameter logs in CSV and XML formats. The software enables batch protocol deployment across multiple instruments—a key requirement for core facilities performing high-throughput cloning or CRISPR library electroporation. Audit trail functionality records operator ID, method name, date/time stamp, parameter set, and error flags, satisfying FDA 21 CFR Part 11 requirements for electronic records when configured with role-based access controls and digital signature modules. Raw pulse data (voltage vs. time) can be exported for post-acquisition analysis in MATLAB or Python-based electrophysiology toolkits.

Applications

• Mammalian cell transfection: Stable and transient delivery of plasmids, siRNA, mRNA, and CRISPR-Cas9 ribonucleoproteins into suspension and adherent lines—including hard-to-transfect primary cells and iPSC-derived models
• Bacterial and yeast genetic engineering: High-efficiency transformation of large constructs (BACs, YACs) and allelic replacement in Helicobacter pylori, Candida albicans, and industrial Pichia pastoris strains
• In vivo and ex vivo gene delivery: Paired with Model 747 coaxial electrodes for targeted intratumoral, intramuscular, or intra-embryonic (in ovo) electroporation
• Cell fusion: Electrofusion of hybridoma cells, somatic cell nuclear transfer (SCNT), and generation of heterokaryons for membrane protein trafficking studies
• Functional genomics: Genome-scale pooled screening using electroporated sgRNA libraries in immune cell subsets

FAQ

What distinguishes square-wave from exponential decay pulses on the ECM399?
Square-wave pulses maintain constant voltage for a defined duration and are preferred for mammalian cells due to reduced thermal stress and higher viability. Exponential decay pulses deliver initial high voltage that declines exponentially and are optimal for bacterial transformation where rapid membrane permeabilization is required.
Can the ECM399 be used for CRISPR RNP delivery?
Yes—validated protocols exist for Cas9-gRNA ribonucleoprotein complexes in Jurkat, THP-1, and primary CD34+ hematopoietic stem cells using square-wave parameters (e.g., 1600 V, 10 ms, 1 pulse) in 0.1 cm cuvettes.
Is calibration required before regulatory submissions?
While the ECM399 does not require routine recalibration, users conducting GLP or GMP work must perform annual verification using a calibrated oscilloscope and high-voltage probe per internal SOPs aligned with ISO/IEC 17025.
Does BTX provide application support for non-standard cell types?
Yes—BTX Technical Applications Scientists offer free protocol optimization consultations, including empirical parameter sweeps and viability assays, for novel primary isolates, organoids, or tissue explants.
How is data integrity ensured during multi-user lab deployment?
BTX Control Software supports LDAP integration, method locking, and encrypted database logging—enabling full traceability from experiment initiation to final data export in regulated environments.